GENELUX Corp (GNLX) stock
GNLXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.00+0.08 (+4.17%)
Close on Nov 17, 2026Market cap $90.49MP/E –Yield –
Genelux price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Genelux's price to sales ratio was 490.1× on Apr 30, 2024.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2024 | Apr 30, 2024 | 490.1× | +456.7 |
| 2023 | Oct 31, 2023 | 33.4× | – |
See a number that looks wrong?